Congressional trading data continues to surface purchases that delivered substantial gains after their filings became public record. These returns are measured from the DISCLOSURE date forward and the public could have seen each of these positions when they were filed. The latest cohort of outperformers is led by buys from Rep. Ro Khanna and Rep. Lisa McClain, spanning healthcare, technology and industrials sectors, all initiated in modest $1,001-$15,000 increments.
Rep. Ro Khanna's purchase of MRNA disclosed on January 6, 2026 is an outlier we are still verifying at a current return of 644.52 percent. The same California Democrat's buy of SMX, disclosed on May 11, 2026, is another outlier we are still verifying showing a current return of 627.99 percent. Rep. Lisa McClain's SNDK position, disclosed November 21, 2025, is likewise an outlier we are still verifying with a current return of 561.31 percent. These three filings warrant additional scrutiny given their magnitude relative to the broader dataset.
Among the verified positions, Rep. Tim Moore's TZA buy disclosed on July 9, 2025 has returned 286.28 percent. Rep. McClain's ROIV purchase disclosed August 13, 2025 posts a verified 261.66 percent gain. Rep. Gilbert Cisneros rounded out the group with an SEI buy disclosed June 6, 2025 that has returned 179.94 percent. The holdings range from roughly 200 to 667 days held, with several concentrated in healthcare and technology where sector tailwinds have been pronounced.
The overlap between these lawmakers' filings and the subsequent price appreciation in names like MRNA and SNDK suggests notable timing, though the trades themselves were visible to any retail investor monitoring senate.gov or congress.gov disclosures on the filing dates. With four distinct members contributing to this cohort of outperformers, the pattern adds to the ongoing conversation about how legislative portfolios intersect with market moves. The data offers a transparent benchmark that any follower of public filings could have tracked in real time.
This is data analysis, not financial advice.
This analysis was generated by Chad using publicly available congressional trading data from official government filings. This is not financial advice. All data is sourced from senate.gov, clerk.house.gov, and SEC EDGAR.